Volume 2, Issue 11, Page 6 (November 2006)
12 of 33
PREVIEW
FULL TEXT
FULL-TEXT PDF (57 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The Food and Drug Administration's approval of donepezil for the treatment of severe dementia in people with Alzheimer's disease is not expected to end controversy over the agent's usefulness in patients with various degrees of dementia.
PII: S1553-3212(06)71703-4
doi:10.1016/S1553-3212(06)71703-4
© 2006 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.